ATE125362T1 - Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung. - Google Patents

Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.

Info

Publication number
ATE125362T1
ATE125362T1 AT89902488T AT89902488T ATE125362T1 AT E125362 T1 ATE125362 T1 AT E125362T1 AT 89902488 T AT89902488 T AT 89902488T AT 89902488 T AT89902488 T AT 89902488T AT E125362 T1 ATE125362 T1 AT E125362T1
Authority
AT
Austria
Prior art keywords
antibodies
produce
monoclonal antibodies
cell lines
hybrid cell
Prior art date
Application number
AT89902488T
Other languages
English (en)
Inventor
Margo P Cohen
Original Assignee
Exocell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exocell Inc filed Critical Exocell Inc
Application granted granted Critical
Publication of ATE125362T1 publication Critical patent/ATE125362T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89902488T 1988-01-25 1988-12-15 Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung. ATE125362T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/147,363 US5223392A (en) 1988-01-25 1988-01-25 Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore

Publications (1)

Publication Number Publication Date
ATE125362T1 true ATE125362T1 (de) 1995-08-15

Family

ID=22521270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89902488T ATE125362T1 (de) 1988-01-25 1988-12-15 Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.

Country Status (7)

Country Link
US (1) US5223392A (de)
EP (1) EP0358739B1 (de)
JP (1) JP3026818B2 (de)
AT (1) ATE125362T1 (de)
AU (1) AU3066489A (de)
DE (1) DE3854194T2 (de)
WO (1) WO1989006798A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284777A (en) * 1991-03-04 1994-02-08 Isolab, Inc. Combined glycated hemoglobin and immunoturbidometric glycated albumin assay from whole blood lysate
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
US5518720A (en) * 1992-12-30 1996-05-21 Exocell, Inc. Treatment of complications of diabetes with substances reactive with the fructosyl-lysine structure in glycated albumin
DE4308532A1 (de) * 1993-03-17 1994-09-22 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen in vivo glykiertes Albumin
US6551593B1 (en) * 1995-02-10 2003-04-22 Millennium Pharmaceuticals, Inc. Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US7750137B2 (en) * 1995-09-01 2010-07-06 Millennium Pharmaceuticals, Inc. Mucosal vascular addressins
US7803904B2 (en) * 1995-09-01 2010-09-28 Millennium Pharmaceuticals, Inc. Mucosal vascular addressing and uses thereof
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
EP0769697A1 (de) 1995-10-18 1997-04-23 Kyoto Daiichi Kagaku Co., Ltd. Trockentestgerät zum Nachweiss glykosiliertes Albumins
US5811242A (en) * 1995-10-24 1998-09-22 Tokuyama Corporation Marker and reagent for diabetes mellitus and diabetes mellitus complication
US6355680B1 (en) * 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
US5908925A (en) * 1996-06-27 1999-06-01 Exocell, Inc. Genetically engineered immunoglobulins with specificity for glycated albumin
US7147851B1 (en) * 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20030215952A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
MXPA01010489A (es) * 1999-04-15 2002-05-06 Fox Chase Cancer Ct Metodo para reducir la susceptibilidad a la formacion de tumores inducidos por la desoxiglucosona y sus precursores.
US6835545B2 (en) 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes
JP5179011B2 (ja) * 2002-10-09 2013-04-10 ディーエムアイ バイオサイエンシズ インコーポレイテッド 胎盤虚血および多臓器不全のモニタリング
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
WO2005031356A1 (en) * 2003-09-23 2005-04-07 Epinex Diagnostic, Inc. Rapid test for glycated albumin
US20060089316A1 (en) * 2004-10-25 2006-04-27 Brown Truman R Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
US7833725B2 (en) 2005-01-06 2010-11-16 President And Fellows Of Harvard College Mass spectrometric methods and products
US20070015291A1 (en) * 2005-07-18 2007-01-18 Smith Henry J Rapid test for glycated albumin in blood
US20090042237A1 (en) * 2007-08-06 2009-02-12 Henry John Smith Aptamer based point-of-care test for glycated albumin
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
US20100167306A1 (en) * 2008-12-26 2010-07-01 Henry John Smith Rapid test for glycated albumin in saliva
US9068006B2 (en) 2010-08-25 2015-06-30 President And Fellows Of Harvard College Glycated CD59 peptides, their preparation, and uses thereof
MX367097B (es) 2011-05-02 2019-08-05 Millennium Pharm Inc FORMULACION PARA ANTICUERPO ANTI-A4ß7.
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
EP2766728B1 (de) 2011-10-13 2017-09-06 Boston Heart Diagnostics Zusammensetzungen und verfahren zur behandlung und prävention von koronarer herzkrankheit
SG11201406455YA (en) * 2012-04-17 2014-11-27 Univ Aarhus SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT
CN102914656B (zh) * 2012-07-23 2014-10-29 四川新健康成生物股份有限公司 间接免疫法糖化血清白蛋白检测试剂盒
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
EP3220810A4 (de) 2014-11-17 2018-05-16 Boston Heart Diagnostic Corporation Beurteilung des risikos für herz-kreislauf-erkrankungen
CN104990879A (zh) * 2015-07-02 2015-10-21 董静平 血清糖化白蛋白含量测定方法及测定试剂盒
EP3726215A4 (de) 2017-12-12 2022-01-19 DxGen Corp. Kieselsäurenanopartikel zur biomarkerdiagnose und verfahren zur herstellung davon
CN109828112B (zh) * 2019-03-02 2022-02-15 浙江康特生物科技有限公司 糖化白蛋白抗体复合物制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629692A (en) * 1982-12-06 1986-12-16 Miles Laboratories, Inc. Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia
US4837170A (en) * 1986-01-20 1989-06-06 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor
US4797473A (en) * 1986-06-25 1989-01-10 Regents Of The University Of Minnesota Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
DE3781745T2 (de) * 1986-08-22 1993-02-04 Miles Inc Antikoerper zur verwendung fuer die bestimmung von menschlichem glycoalbumin.

Also Published As

Publication number Publication date
EP0358739A1 (de) 1990-03-21
WO1989006798A1 (en) 1989-07-27
EP0358739B1 (de) 1995-07-19
US5223392A (en) 1993-06-29
EP0358739A4 (en) 1991-07-03
JP3026818B2 (ja) 2000-03-27
JPH02503059A (ja) 1990-09-27
DE3854194T2 (de) 1996-03-21
DE3854194D1 (de) 1995-08-24
AU3066489A (en) 1989-08-11

Similar Documents

Publication Publication Date Title
ATE125362T1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
ATE94205T1 (de) Monoklonale antikoerper gegen melanoma-assoziierte antigene, hybridzellinien, die diese antikoerper produzieren, und ihre verwendung.
DE3687779D1 (de) Trichotecenkonjugate.
NO165556C (no) Monoklonale antistoff samt derivater derav med hoey affinitet til human-renin og sturkturelt lignende renin for in vitro anvendelse.
DE68918867D1 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
KR880006357A (ko) 인터류킨-i에 대한 항체
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
ATE58554T1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
IL76142A0 (en) Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof
DE69535719D1 (de) Fas-antigenbindender ligand
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
ES8800351A1 (es) Un procedimiento para preparar un anticuerpo monoclonal
DK21985A (da) Monoklonale antistoffer mod ikke-smaacellet lungecancer
FI853283A7 (fi) Uudet monoklonaaliset glykokonjugaattien vasta-aineet, menetelmät niiden tuottamiseksi, ja niiden käytöt.
GB2083836A (en) Monoclonal antibody
ES2051737T3 (es) Antigenos, anticuerpos y metodos para la identificacion de tumores humanos metastasicos, y lineas celulares para producir dichos anticuerpos.
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
EP0273453A3 (de) Hybridoma-Zellinien und monoklonale Antikörper gegen Angiotensin-II
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
DE60042273D1 (de) Antitumorantikörper, proteine und deren verwendung
ATE40116T1 (de) 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.
RU98104739A (ru) Штамм культивируемых клеток мышиной гибридомы, используемый для получения моноклональных антител к ядрышковому антигену, ассоциированному с клеточной пролиферацией

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee